Description
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
| Purity | ≥70% |
|---|---|
| Formula | C16H14N2O4 |
| Formula Wt. | 298.29 |
| Appearance | Red Powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
Pipaón C, Gutierrez P, Montero JC, et al. Mitogen-activated protein kinase routes as targets in the action of diaza-anthracene compounds with a potent growth-inhibitory effect on cancer cells. Mol Cancer Ther. 2002 Aug;1(10):811-9. PMID: 12492114.
Pyrrolidone; NMDA and mGluR5 agonist, N-type an...
Polyphenol derivative of caffeic acid found in ...
JAK2 inhibitor.
Thienopyridine; P2Y12 antagonist.
Endogenous peptide hormone, GLP-1 fragment, inv...
Calcitonin-family peptide frgament, involved in...
4-Hydroxytamoxifen prodrug; FIASMA, SERM, PKC i...
mTOR inhibitor.
JAK2 inhibitor.
Synthetic quinone CoQ analog, promotes mitochon...
B-Raf inhibitor.
Pim kinase inhibitor.
Vitamin B6 derivative, antioxidant.
Endogenous peptide fragment, involved in vasoco...
Endogenous bombesin-related peptide, involved i...
Synthetic ITC, erucin analog.
Impurity of omeprazole
AurKA inhibitor.
BRD2/4/9 and CECR2 inhibitor.
Tropane alkaloid found in Solanaceae plants; α...